title: Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis.
authors.forename: Nadeem A
authors.initials: NA
authors.lastname: Qazi
authors.forename: John F
authors.initials: JF
authors.lastname: Morlese
authors.forename: D Michael
authors.initials: DM
authors.lastname: King
authors.forename: Rizvana S
authors.initials: RS
authors.lastname: Ahmad
authors.forename: Brian G
authors.initials: BG
authors.lastname: Gazzard
authors.forename: Mark R
authors.initials: MR
authors.lastname: Nelson
mesh_terms: D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D006177:Gynecomastia / Q000209:etiology*; D006679:HIV Seropositivity / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015497:HIV-1; D006801:Humans; D008297:Male; D010078:Oxazines / Q000009:adverse effects*; D012367:RNA, Viral / Q000097:blood
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D012367:RNA, Viral; C098320:efavirenz